Sudeep Pharma Limited (SUDEEPPHRM) — Corporate Action

📢 Key Event
Board approves final dividend of Rs 1.50 per share for FY2025-26

🔄 What Changed
Final dividend recommended at Rs 1.50 per share (150% of face value)

🔮 What's Next
Dividend approval pending shareholder vote at upcoming AGM

💡 Investor Takeaway
Shareholders will vote on the proposed dividend at the upcoming AGM, making it contingent on approval.

Sudeep Pharma Limited announced a final dividend of Rs 1.50 per share (150% of face value) for FY2025-26, approved by its board on 21 May 2026, pending shareholder approval at the upcoming AGM. The filing includes audited standalone and consolidated financial results for the year ended 31 March 2026, reporting total income of Rs 37,700.94 lakhs and profit after tax of Rs 10,758.07 lakhs. The company also disclosed IPO proceeds utilization, including Rs 7,581.40 lakhs for capital expenditure and Rs 1,252.19 lakhs for general corporate purposes, with Rs 1,352.19 lakhs remaining unutilized as term deposits. Additionally, it confirmed the appointment of Chetan Gandhi & Associates as cost auditor and H M Mehta & Associates as secretarial auditor for five consecutive years starting 2026-27.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUDEEPPHRM ✨ Ask AI About This